Calgary Scientific Inc. announced a partnership and distribution agreement with Apollo PACS. Calgary Scientific’s ResolutionMD enterprise image-viewer will be integrated with the Apollo Enterprise Patient Multimedia Manager (Apollo EPMM) to extend Web and mobile image access. The integration will help physicians make more informed decisions by enabling quick and secure access to medical images using desktop, Web or mobile devices.

Apollo Enterprise Patient Multimedia Manager

TEE, 3-D TEE, 4-D TEE, GE
TEE, 3-D TEE, 4-D TEE, GE

Transesophageal echocardiography (TEE) is quickly establishing itself as an essential tool in the interventional cardiologist’s daily toolbox. An alternative to the more traditional transthoracic echo, TEE provides higher quality images due to the esophagus’ location directly behind the heart. With the introduction of 3-D/4-D TEE, the technology has become a primary imaging modality to guide new, complex transcatheter structural heart procedures, including transcatheter aortic valve repair (TAVR), MitraClip, transcatheter mitral valve replacements (TMVR), left atrial appendage (LAA) occlusions, and septal defect closures. 
 

Vital Images Inc. announced the release of VioSuite Image Management and Vitality Solutions Business Intelligence, giving healthcare administrators a robust set of tools to improve system-wide image access and image data analytics. Vital will introduce the VioSuite and Vitality Solutions portfolios at the 2015 Healthcare Information and Management Systems Society annual conference (HIMSS15), April 13-15 in Chicago.

Vitality Solutions Business Intelligence

VioSuite Image Management

The World Molecular Imaging Society (WMIS) announced the kick-off of a collaboration with the National Cancer Institute (NCI) to promote best practices for co-clinical trials. The goal of the collaboration is to speed the discovery of more and better treatments for cancer and other diseases. NCI is part of the National Institutes of Health (NIH).

The United Kingdom is to get its first three proton beam therapy centers, marking a significant breakthrough in the provision of cancer treatment. Cardiff-based Proton Partners International Ltd is to open the treatment centers in Cardiff, London and Northumberland by 2017; the first - Cardiff - will be operational next year. The centers will be available for National Health Service (NHS) patients from England, Scotland and Wales, medically-insured private patients and self-paying patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now